K
Kyungdong Pharm
KOSDAQ:011040
Kyungdong Pharm
KOSDAQ:011040
Price:
5 340
KRW
-0.56%
Market Closed
Market Cap:
₩164.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kyungdong Pharm
KOSDAQ:011040
|
KR |
|
Bank Linth LLB AG
SIX:LINN
|
CH |
|
Clear Sale SA
BOVESPA:CLSA3
|
BR |
|
Lion E Mobility AG
XETRA:LMIA
|
CH |
|
L
|
Lotus Ventures Inc
CNSX:J
|
CA |
|
Arvind Fashions Ltd
NSE:ARVINDFASN
|
IN |
|
H
|
Huvitz Co Ltd
KOSDAQ:065510
|
KR |
|
SDIC Power Holdings Co Ltd
SSE:600886
|
CN |
|
M
|
Meltronix Inc
OTC:MTNX
|
US |
|
Apollo Pipes Ltd
NSE:APOLLOPIPE
|
IN |
Multiples-Based Value
The Multiples-Based Value for Kyungdong Pharm (011040) under the Base Case is hidden KRW. Compared with the current market price of 5 340 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Kyungdong Pharm Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Kyungdong Pharm Competitors
Kyungdong Pharm Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kyungdong Pharm
KOSDAQ:011040
|
164.3B KRW | 0.7 | 17.4 | 14.9 | 23.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.9 | 43.9 | 29.6 | 31.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.5 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
